Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018). Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. Front Pharmacol.
Chicago-tyylinen lähdeviittausRoseman, Leor, David J. Nutt, ja Robin L. Carhart-Harris. "Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression." Front Pharmacol 2018.
MLA-viiteRoseman, Leor, David J. Nutt, ja Robin L. Carhart-Harris. "Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression." Front Pharmacol 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.